SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the December 2022 quarter moved down -37.84% to Rs. 633.27 millions as compared to Rs. 1018.78 millions during the year ago period.The company suffered a huge decline of -89.43% to Rs. 4.25  millions from Rs. 40.20 millions  of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 66.03 millions from 143.11 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 633.27 1018.78 -37.84 2811.48 3296.79 -14.72 4510.68 3846.98 17.25
Other Income 1.35 0.00 0.00 1.42 5.22 -72.80 0.89 0.00 0.00
PBIDT 66.03 143.11 -53.86 254.20 389.44 -34.73 491.45 580.20 -15.30
Interest 32.18 26.87 19.76 93.18 86.27 8.01 111.62 93.26 19.69
PBDT 33.85 116.24 -70.88 161.02 303.17 -46.89 379.83 486.94 -22.00
Depreciation 28.83 26.72 7.90 82.39 75.63 8.94 102.49 91.75 11.71
PBT 5.02 89.52 -94.39 78.63 227.54 -65.44 277.34 395.19 -29.82
TAX 0.77 49.32 -98.44 22.07 97.90 -77.46 80.76 115.48 -30.07
Deferred Tax 2.00 11.19 -82.13 -0.50 22.86 -102.19 -7.32 22.80 -132.11
PAT 4.25 40.20 -89.43 56.56 129.64 -56.37 196.58 279.71 -29.72
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 10.43 14.05 -25.77 9.04 11.81 -23.46 10.90 15.08 -27.76

Mangalam Drugs&Org. Share Price

29.75 0.02 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×